Gateway to Think Tanks
来源类型 | Discussion paper |
规范类型 | 论文 |
来源ID | DP15512 |
DP15512 A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development | |
Lucas Böttcher; Hans Gersbach | |
发表日期 | 2020-12-03 |
出版年 | 2020 |
语种 | 英语 |
摘要 | Starting from a general framework for the study of antibiotic-resistance, we introduce a market-based refunding scheme that incentivizes companies to develop antibiotics against resistant bacteria and, in particular, narrow-spectrum antibiotics that target specific resistant bacterial strains. Successful companies can claim a refund from a newly-established antibiotics fund that partially covers their development costs. The refund involves a fixed and variable part. The latter increases with the use of the new antibiotic for resistant strains-the "resistance premium"-and it decreases with the use for non-resistant bacteria-the "non-resistance penalty". We outline how such a refunding scheme can solve the so-called "antibiotics dilemma", which states that new antibiotics against resistant bacteria are of high societal value, but unattractive for companies, since sales are low. We illustrate that the refunding scheme can cope with various sources of R&D uncertainty and we discuss how the antibiotics fund could be financed. |
主题 | Industrial Organization |
关键词 | Antibiotic-resistance - antibiotics dilemma - r&d incentives - refunding scheme - narrow-spectrum antibiotics - r&d uncertainty |
URL | https://cepr.org/publications/dp15512 |
来源智库 | Centre for Economic Policy Research (United Kingdom) |
资源类型 | 智库出版物 |
条目标识符 | http://119.78.100.153/handle/2XGU8XDN/544514 |
推荐引用方式 GB/T 7714 | Lucas Böttcher,Hans Gersbach. DP15512 A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development. 2020. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[Lucas Böttcher]的文章 |
[Hans Gersbach]的文章 |
百度学术 |
百度学术中相似的文章 |
[Lucas Böttcher]的文章 |
[Hans Gersbach]的文章 |
必应学术 |
必应学术中相似的文章 |
[Lucas Böttcher]的文章 |
[Hans Gersbach]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。